UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000025979
Receipt number R000029665
Scientific Title Accelerometer assessment of daily physical activity and prognosis after catheter ablation of atrial fibrillation
Date of disclosure of the study information 2017/03/01
Last modified on 2019/08/06 18:03:58

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Accelerometer assessment of daily physical activity and prognosis after catheter ablation of atrial fibrillation

Acronym

Accelerometer assessment of daily physical activity and prognosis after catheter ablation of atrial fibrillation

Scientific Title

Accelerometer assessment of daily physical activity and prognosis after catheter ablation of atrial fibrillation

Scientific Title:Acronym

Accelerometer assessment of daily physical activity and prognosis after catheter ablation of atrial fibrillation

Region

Japan


Condition

Condition

Atrial fibrillation

Classification by specialty

Cardiology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate daily physical activity and prognosis after catheter ablation of atrial fibrillation

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

AF recurrence after the ablation

Key secondary outcomes

Physical activity, degree of AF symptoms


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Maneuver Other

Interventions/Control_1

Assessment of daily physical activity using accelerometer and questionnaire from 3-4 weeks before to 6 months after the ablation procedure

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

1) Patients who are scheduled to undergo catheter ablation of AF for the first time in Nagoya university hospital
2) Patients who are able to put on anccelerometer and are followed-up during 6 months after the ablation.

Key exclusion criteria

Patients who do not agree the study inclusion

Target sample size

30


Research contact person

Name of lead principal investigator

1st name Satoshi
Middle name
Last name Yanagisawa

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Advanced Cardiovascular Therapeutics

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

TEL

81-52-744-2147

Email

yanagisawa-sato@med.nagoya-u.ac.jp


Public contact

Name of contact person

1st name Satoshi
Middle name
Last name Yanagisawa

Organization

Nagoya University Graduate School of Medicine

Division name

Department of Advanced Cardiovascular Therapeutics

Zip code

466-8550

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi, 466-8550, Japan.

TEL

81-52-744-2147

Homepage URL


Email

yanagisawa-sato@med.nagoya-u.ac.jp


Sponsor or person

Institute

Nagoya University Graduate School of Medicine. Department of Advanced Cardiovascular Therapeutics

Institute

Department

Personal name



Funding Source

Organization

Grant-in-Aid for Scientific Research
Suzuken Memorial Foundation

Organization

Division

Category of Funding Organization

Non profit foundation

Nationality of Funding Organization

Japan


Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The Nagoya University Ethics Committee

Address

65 Tsurumai-cho, Showa-ku, Nagoya, Aichi4668550, Japan.

Tel

81-52-744-2423

Email

camcr@med.nagoya-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

名古屋大学医学部附属病院(愛知県)


Other administrative information

Date of disclosure of the study information

2017 Year 03 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

20

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2017 Year 01 Month 28 Day

Date of IRB

2017 Year 05 Month 26 Day

Anticipated trial start date

2017 Year 05 Month 26 Day

Last follow-up date

2019 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2017 Year 02 Month 02 Day

Last modified on

2019 Year 08 Month 06 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000029665


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name